Dr. Ajay K. Gopal
Claim this profileFred Hutch/University of Washington Cancer Consortium
Studies Lymphoma
Studies Follicular Lymphoma
9 reported clinical trials
14 drugs studied
Area of expertise
1Lymphoma
CD30 positive
Stage II
Stage III
2Follicular Lymphoma
Stage II
Stage III
Stage IV
Affiliated Hospitals
Fred Hutch/University Of Washington Cancer Consortium
Fred Hutchinson Cancer Research Center
Clinical Trials Ajay K. Gopal is currently running
Low Dose Mosunetuzumab
for Lymphoma
This phase II trial tests the safety, side effects and effectiveness of mosunetuzumab in treating patients with slow growing (indolent) B-cell lymphoma. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread.
Recruiting1 award Phase 25 criteria
Brentuximab +/− Nivolumab
for Lymphoma
This phase II pilot trial studies how well brentuximab vedotin with or without nivolumab works in treating patients with CD30+ lymphoma that has come back after a period of improvement or does not respond to treatment. Biological therapies, such as brentuximab vedotin, may stimulate the immune system in different ways and stop cancer cells from growing. Monoclonal antibodies, such as nivolumab may interfere with the ability of tumor cells to grow and spread. Giving brentuximab vedotin with or without nivolumab may work better in treating patients with CD30+ lymphoma.
Recruiting1 award Phase 2
More about Ajay K. Gopal
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Ajay K. Gopal has experience with
- Brentuximab Vedotin
- Carboplatin
- Etoposide
- Ifosfamide
- Nivolumab
- Mosunetuzumab
Breakdown of trials Ajay K. Gopal has run
Lymphoma
Follicular Lymphoma
Non-Hodgkin's Lymphoma
MALT Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ajay K. Gopal specialize in?
Ajay K. Gopal focuses on Lymphoma and Follicular Lymphoma. In particular, much of their work with Lymphoma has involved CD30 positive patients, or patients who are Stage II.
Is Ajay K. Gopal currently recruiting for clinical trials?
Yes, Ajay K. Gopal is currently recruiting for 4 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Ajay K. Gopal has studied deeply?
Yes, Ajay K. Gopal has studied treatments such as Brentuximab Vedotin, Carboplatin, Etoposide.
What is the best way to schedule an appointment with Ajay K. Gopal?
Apply for one of the trials that Ajay K. Gopal is conducting.
What is the office address of Ajay K. Gopal?
The office of Ajay K. Gopal is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.